NM_000492.3:c.2988+1G>A

HGVS Expressions

  • NG_016465.4:g.145971G>A
  • NM_000492.3:c.2988+1G>A
  • NP_000483.3:p.?
  • NC_000007.14:g.117606754G>A
Back to search Result
Clinvar Clinical Significance

Pathogenic

CTGA Clinical Significance

Likely Pathogenic, Pathogenic

Variant Type

Substitution

Clinvar

7224

Epidemiology in the Arab World

View Map
Subject IDCountry of OriginAllele CountAllele FrequencyCTGA Clinical Significance Condition(s)ReferenceRemarks
219700.1Bahrain1NAPathogenicCystic FibrosisEskandarani, 2002 Compound heterozygous patient
219700.52United Arab Emirates2NAPathogenicCystic FibrosisSaleheen and Frossard, 2006
219700.60Saudi Arabia2NAPathogenicCystic FibrosisEl-Harith et al. 1997 Patient number 'CF10' in the publication
219700.61Saudi Arabia2NAPathogenicCystic FibrosisEl-Harith et al. 1997 Patient number 'CF16' in the publication
219700.62Saudi Arabia2NAPathogenicCystic FibrosisEl-Harith et al. 1997 Patient number 'CF46' in the publication
219700.63Saudi Arabia2NAPathogenicCystic FibrosisEl-Harith et al. 1997 Patient number 'CF49' in the publication
219700.74United Arab Emirates2Likely PathogenicCystic FibrosisAlsamri et al. 2020
219700.G.2.6KuwaitNANAPathogenicCystic FibrosisSamilchuk, 2005 Unknown number of patients
219700.G.10Saudi Arabia6NAPathogenicCystic FibrosisDörk et al. 1998 Three patients of Saudi origin
219700.G.14.5United Arab EmiratesNANAPathogenicCystic FibrosisShafiq et al.2021 Mutations reported with a population fre...
© CAGS 2024. All rights reserved.